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Background:  Pregnant  women  remain  the  most  vulnerable  high-risk  population  to the  devastating  impact
of the  on-going  human  immunodeﬁciency  virus  (HIV)  generalized  epidemic  and  co-infection  with  Tuber-
culosis  in  Nigeria.  By  the  end  of  2017,  the  country  ranked  the  second  highest  in  adult  HIV-infected
individuals and  the highest  population  of orphans  due  to AIDS  in  sub-Saharan  Africa.  We  assessed  the
epidemiology  of  HIV among  pregnant  women  across  ten facilities  in  south-west  Nigeria.
Methods:  This  is  a cross-sectional  study  design  in which  353  pregnant  women  randomly  selected  across
ten  health  care  facilities  in two  states  in  south  west  Nigeria.  This  study  was  conducted  between  January
and  May  2015.  HIV  testing  was  conducted  and  active  tuberculosis  screening  was  implemented  using the
ﬂuorescence  microscopy.  In addition,  a  structured  questionnaire  was  administered  to  elicit  risk factors
of HIV  infection  and syndromic  Tuberculosis  in the study  population.
Results:  We  found  a 5.1%  (18/353:95%  CI:3.0%–8.0%)  rate  of HIV and  0%  active  tuberculosis  in  the study
population.  HIV positive  pregnant  women  were  6  times  more  likely  to have  blood  transfusion  with  greater
odds  of  infection  found  in  pregnant  women  with  history  of  blood  transfusion  in  the  previous  three  months
(OR:3.27,  95%  CI:0.44–24.36).  Pregnant  women  who  tested  HIV negative  had 70%  reduction  in  odds  of
infection  (OR:0.21:95%  CI:0.06–0.77).
Conclusions:  This study  suggests  a possible  strong  epidemiological  link  between  HIV  infection  and  recent
blood  transfusion  among  pregnant  women  attending  ante-natal  clinics  in  south  west  Nigeria.  We  there-
fore recommend  further  study  to develop  a more  robust  estimate  of  blood  transfusion  and  the  risk  of HIV
in pregnant  women  in  Nigeria.
© 2018  The  Authors.  Published  by  Elsevier  Limited  on  behalf  of  King  Saud  Bin Abdulaziz  University
for  Health  Sciences.  This  is  an  open  access  article  under  the CC  BY-NC-ND  license  (http://ntroduction
The dual burden of HIV and TB remains a major threat to
ll countries in sub-Saharan Africa with signiﬁcant country-level
rogress reported at the end of 2016. According to the recent global
uberculosis report [1], Nigeria ranks fourth among the six coun-
ries that account for 60% of all new TB infections behind India,
ndonesia, and China, and ahead of Pakistan and South Africa.
onsequently, recent trend makes Nigeria the highest TB bur-
ened country in sub-Saharan Africa, a position it has retained
ver the past ﬁve years. In 2016, an estimated 10.4 million new TB
∗ Corresponding author at: Department of Biological Sciences, Redeemers Univer-
ity,  Ede, Osun State, Nigeria
ttps://doi.org/10.1016/j.jiph.2018.06.004
876-0341/© 2018 The Authors. Published by Elsevier Limited on behalf of King Saud Bi
C  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).creativecommons.org/licenses/by-nc-nd/4.0/).
cases were reported worldwide of which 11% (1.2 million) occurred
among HIV-infected populations. Evidence over the past decade has
increasingly demonstrated the commitment of the country towards
ending the HIV and tuberculosis epidemic campaign by 2030 with
8% performance gap reported between incident and notiﬁed cases
in 2017 [1]. With the most recent estimates of 3.2 million people
living with HIV/AIDS in the country (of which only 30% are on anti-
retroviral treatment), and a reported 220,000 incident cases of HIV
infections in year 2016 alone [2], signiﬁcant challenge persists to
progress. The extended generalized HIV epidemic and syndemic
with tuberculosis remain a signiﬁcant cause of morbidity and mor-
tality in pregnant women  in Nigeria and children under ﬁve years
worldwide, of which more than 70% of the attributable proportion
of the burden is in sub-Saharan Africa [2]. For instance, compli-
cations due to HIV infection or TB in pregnant women have been
n Abdulaziz University for Health Sciences. This is an open access article under the
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eported by several studies [3–5]. Recent intervention efforts have,
herefore, been targeted at this high-risk group as maternal health
s a vital indicator of overall health of the general population.
Over the past 40-year history of the HIV epidemic in Nigeria,
regnant women have been particularly vulnerable and severely
ffected due to the compromised state of their immunity, risk of
ransmission from most recent partners, and onward transmission
o unborn child [6–8]. Consequent upon this, several indicators
ave been formulated to assess the quality of maternal health to
onitor progress. Studies have shown that pregnant women  living
ith HIV have between 2–10 times increased risk of mortality than
ninfected pregnant women [9]. More worrisome, is the strong evi-
ence for the additional risk in pregnant women in low-resourced
ettings such as sub-Saharan Africa with signiﬁcantly higher prob-
bility of maternal (and consequently child) deaths [10].
TB reactivation in pregnant women has been found to be a
igniﬁcant risk factor for HIV infection with about 5–10% risk of
eactivation per year [11]. This TB-triggered HIV acquisition can
ccur through a number of possible pathways. For instance, a preg-
ant woman may  acquire infection during multiple heterosexual
artnerships or lowered consistency in the use of condom with a
igh risk partner as is often the case in various parts of sub-Saharan
frican countries.
While few studies have been conducted to characterize the
ature of HIV and TB burden among pregnant women  in Nigeria,
urrent estimates of HIV and TB burden in Nigeria varies between
he range of 5% and 10% rates of co-infection according to pub-
ished studies in various parts of the country. Emerging prevalence
atterns suggest that signiﬁcant variation still persists across the
ix geopolitical zones of Nigeria, which may  underlie the qual-
ty of maternal and child health services available, accessible, and
ffordable at various levels and point of care across the country.
or example, in a recent large scale study conducted by Alan et al.
12], among HIV clients across Global Fund supported facilities in
igeria, the prevalence of HIV among TB patients in Nigeria was
eported at 22%. Co-infection rate was found to be 8.3%, 6.7% and
.6% in 2013, 2014 and 2015 respectively. The study also reported
ighest rate (10.3%) of co-infection in the south-east region of the
ountry followed by south-west region at 8.3% [12].
In a separate study by Nwabuko et al. [13], a 5.9% prevalence rate
f TB co-infection was found in the Niger Delta region of Nigeria
mong HIV patients [13]. However, higher HIV co-infection burden
as been reported by studies conducted in TB patients in the south-
estern region of the country. For example, a 25% HIV co-infection
ate was reported by Matthew et al. in a cohort of TB patients on
irectly observed therapy [14]. Similarly, Odaibo et al. observed a
2.3% HIV-TB co-infection rate in a multi-DOTS center study in Oyo
tate [15]. A more recent four-year retrospective study in Ogun
tate by Koladeet al. (2016) reported a 29% prevalence of HIV co-
nfection in a cohort of TB patients [16]. The same authors reported
 3.5% prevalence rate of TB among a separate cohort of HIV patients
n Ogun State [16]. These studies suggest a higher probability of HIV
cquisition in TB patients than observed rate of tuberculosis in HIV
nfected patients.
The WHO  End TB Strategy approved by the World Health Assem-
ly in 2014, calls for a 90% reduction in TB deaths, and a further
0% reduction in new infections by 2030 relative to 2015 rates [1].
ith regard to progress in treatment, signiﬁcant evidence of suc-
ess has been found across all categories of TB patients in Nigeria,
ver the past 15 years. However, progress remains impeded due
o the problem of universal coverage as only 25% of diagnosed TB
atients partly or fully have access to the appropriate treatment.It is also worth mentioning that prominent authors have argued
gainst the possibility of attaining the 90-90-90 UN test and treat
arget by 2020, especially in resource-constrained countries in sub-
aharan Africa [17]. In an attempt to assess this presumption, Levi Public Health 11 (2018) 826–833 827
et al. [18] conducted a systematic analysis of country-level HIV
treatment cascades in both developing and developed countries.
Their study revealed that of the 69 country cascades analyzed (cat-
egorized as complete for 4 stages or partial for 3 stages), none has
so far achieved the 90% diagnosis target, with the highest of 87%
observed in the Netherlands. The highest rate of treatment cov-
erage and viral suppression were 71% and 68% respectively both
observed in Switzerland [18].
Sadly, comparable statistical estimates are unavailable to mea-
sure any improvement or lack of it in Nigeria. Indeed, a country
rarely makes any worthwhile progress until it makes the health
and wellbeing of her pregnant women  and nursing mothers an
over-arching national health priority as demonstrated by devel-
oped countries.
From our review of the literature on HIV and TB infection and co-
infection in the pregnant women  population in Nigeria, few studies
have been conducted especially in recent times in keeping with
monitoring the trend. This study is therefore an attempt to ﬁll this
gap in knowledge in south-west Nigeria.
Materials and methods
Study design, site and study population
This study is a cross-sectional survey designed to be representa-
tive of pregnant women  population visiting ten healthcare facilities
for antenatal care and related services across two  contiguous states
(Lagos and Ogun) in south-west Nigeria between the period of
August 2014 and May  2015.
These study sites were selected by their local government areas
which are locations of an ongoing maternal and child health related
interventions by the Redeemed Action Programme Action Commit-
tee on AIDS (RAPAC), one of the most renown non-governmental
agency with intervention activities across south-west Nigeria for
the past 20 years. In this study, pregnant women were randomly
selected from the following locations as presented in Table 1along
with the average population size of pregnant women  attended to
in each maternity in a year.
Lagos is a metropolitan state that shares borders with Ogun
State. We  considered 5 of the most affected communities in each
state by the local government areas, in order to determine the
HIV/TB disease burden and exposure risk among the population
of pregnant women attending antenatal services. The local gov-
ernment areas in Lagos States include Abule Iroko, Agbado, Ipaja,
Kollington and Ikorodu, while selected locations in Ogun states
include Ibafo, Mowe, Shagamu, Akute-Ajuwon and the Redemp-
tion camp. Other activities conducted as part of the study include
a community-wide HIV and TB awareness and sensitization pro-
gramme.
Inclusion and exclusion criteria
All pregnant women  between the age bracket of 15 to 49 years
that gave informed consent were considered eligible to participate
in this study. However, nursing mothers and pregnant women  that
are medical personnel as well as birth attendants in the selected
maternities were excluded.
Study sample, sampling method and sample size
In order to obtain the required sample size for this study, we
considered the formula:
Samplesize = Z1 − /22p(1 − p)/d2 (1)
as recommended by Charan and Biswas.
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Table  1
Distribution of study facilities in Lagos and Ogun States and their corresponding geographic coordinates.
Location of maternity centre State Local government area Annual average population size
attending antennal care at maternity
Geographic coordinates of LGA
Mowe  Ogun Obafemi Owode 800 6.80596, 3.43803
Ibafo Ogun Obafemi Owode 700 6.74015, 3.42208
AkuteAjunwo Ogun Ifo NA 6.67777, 3.35871
Agbado crossing Lagos Agbado 280 6.71380, 3.28515
Redemption camp Ogun Obafemi Owode 4500 6.4531, 3.3958
Sabo  Ikorodu Lagos Ikorodu West 3000 6.61941, 3.51045
Ipaja  Lagos Alimosho 120 6.60541, 3.27989
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We  estimated a sample size of 217 for the study using the for-
ula in equation 1 above. Z is the standard normal variate at 5% type
 error (P < 0.05) set at 1.96, p is the expected proportion of pregnant
omen with HIV and TB in South west Nigeria − 0.17 as reported
n a previous study [19]. The absolute error d is the desired level of
recision and was set to 0.05 for the study. As a ﬁnal adjustment
o the sample size, we accounted for a 20% non response resulting
n a ﬁnal sample size of 350. A random selection of 350 pregnant
omen was conducted across the ten health facilities using the
robability proportional to size sample selection model. Each time
 pregnant woman declined to participate in the survey, an appro-
riate replacement (matched by age and pregnancy period) was
onsidered till the required sample size was attained. A sampling
rame (deﬁned as a list of all pregnant women attending antenatal
are in each health facility) was developed.
ata collection
A structured questionnaire was utilized to elicit detail of HIV
nd TB exposure history from study participants that gave consent.
ata was collected on key socio-demographic variables such as age,
ducation, and marital status; Knowledge and exposure variables
ncluding knowledge of HIV transmission, prevention methods, age
t ﬁrst sex, casual and regular sexual partner in the past 3 months,
ultiple sexual partners and history of sexually transmitted infec-
ions in the last three months were considered. We  interviewed
articipants in their ﬁrst language of choice to ensure full and
nformed comprehension. In addition, syndromic screening for par-
icipant’s risk of tuberculosis was also conducted according to the
ational guidelines and WHO’s recommendation. These include:
ough for two weeks or more, weight loss of 3 kg or more in last
 weeks, evidence of lymphadenopathy, fever for two  weeks or
ore and night sweats for two weeks or more. A TB risk score
as subsequently generated. However, only a randomly selected
19 of 120 (1 sample could not be recovered by the laboratory)
articipants were tested for the active TB disease due to cost con-
traint. HIV, TB and HIV-TB co-infection were assessed in the study
articipants. All variables were close-ended in a binary format.
IV test
The HIV status of all study participants was evaluated using
apid test diagnostic kits. Presumptive diagnosis was  carried out
ith the use of Determine
®
giving its high sensitivity (100%) and
peciﬁcity (99.6%). In the event of a positive presumptive diag-
osis, further conﬁrmatory diagnosis was done using Starpac
®
as
ecommended by the National Agency for Control of AIDS (NACA).uberculosis test
A select sub-sample of participants with signiﬁcant syndromic
ndicators of tuberculosis was assessed for the presence of active1200 6.71380, 3.28515
200 6.77880, 3.62178
170 6.69916, 3.26385
tuberculosis using the immune-ﬂuorescence microscopy at the
Lagos Mainland Hospital, Lagos State, Nigeria. The use of this highly
sensitive and speciﬁc staining procedure allowed for the accurate
detection (and otherwise exclusion) of active tubercle bacilli in the
suspected cases.
Data analysis
A descriptive and analytic evaluation on the data to determine
prevalence estimates and participants’ risk proﬁle was conducted.
We describe the distribution of study participants according to the
study locations and by prevalence of HIV infection at each loca-
tion using appropriate summary statistics for both continuous and
discrete responses. The signiﬁcance of association was  reported at
5% probability of type 1 error. Variables that attained statistical
signiﬁcance at a 10% p-value were considered for the multivariate
logistic regression model as a potential predictor of HIV infection
in the study population using a stepwise regression procedure.
Reliability and validity
In an attempt to validate the questionnaire instrument, we
conducted a preliminary ﬁeld assessment of its performance on
20 pregnant women in two rounds and the reliability ratio was
measured so as to determine the reliability of the questionnaire.
The validity of the questionnaire was  evaluated by an experienced
researcher in the ﬁeld of HIV and TB epidemiology. We pre-tested
on a small sample of 20 non-competent participants (i.e. those who
were in management positions) selected across the maternity cen-
ters. The purpose of the research was  explained in order to evaluate
the transparency of questions, the ease of comprehension, as well as
the usefulness and logistics of administration. Consequently, neces-
sary modiﬁcations were made using this information. Participants
that were used for the reliability and validity tests were exempted
from the ﬁnal research since they were informed already of the
research questions and some of them did not qualify using the
inclusion criteria.
Ethical considerations
As part of ethical considerations, participants were asked to sign
a consent form following a preliminary awareness and sensitization
(general and conﬁdential) activity. Participants were taken through
the purpose and details of the study in accordance with the Belmont
Report for ethical conduct of research involving human subjects.
The consent form visibly stated the voluntary nature of the research
indicating that participants could withdraw from the survey should
they decline to further participate in the study. Participants were
identiﬁed by means of an identiﬁcation number printed on the
questionnaire instrument in order to ensure anonymity. Permis-
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Table  2
Distribution of study participants across the ten facilities by socio-demographic characteristics.
Variable Ibafo
(N = 39)
n(%)
Shagamu
(N = 29)
n(%)
Abule Iroko
(N = 20) n(%)
Agbado
crossing
(N = 20) n(%)
Akute
Ajuwon
(N = 40) n(%)
Camp
(N = 51)
n(%)
Ipaja (N = 26)
n(%)
Kollington
(N = 45)
n(%)
Mowe
(N = 43)
n(%)
Sabo Ikorodu
(N = 40) n(%)
Total
(N = 353)
n(%)
Age
15–24 1(2.6) 2(6.9) 4(20.0) 1(5) 2(5) 3(5.9) 4(15.4) 2(4.4) 10(23) 6(15) 35(10)
25–34  29(74.4) 23(79.3) 15(75) 15(75) 31(77.5) 36(70.6) 15(57.7) 31(68.9) 26(61) 24(60) 245(69)
>=35  9(23.1) 4(13.8) 1(5) 4(20) 7(17.5) 12(23.5) 7(26.9) 12(26.7) 7(16) 10(25) 73(21)
Marital status
Single 3(7.7) 0(0.0) 2(10) 0(0) 1(2.5) 0(0) 0(0) 2(4.4) 7(16) 2(5) 17(5)
Married 36(92.3) 29(100) 18(90) 20(100) 39(97.5) 51(100) 26(100) 43(95.6) 36(84) 38(95) 336(95)
State  of residence Ogun Lagos
Ogun 39(0.0) 29(100) 12(60) 14(70) 40(100) 50(98) 0(0.0) 0(0) 43(100) 0(0) 227(64)
Lagos  0(0.0) 0(0.0) 8(40) 6(30) 0(0) 1(2) 26(100) 45(100) 0(0) 40(100) 126(36)
Education
None  1(2.6) 0(0.0) 0(0) 2(10) 2(5.1) 0(0) 1(4) 1(2.2) 0(0) 0(0) 7(2)
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ion to conduct this study was also obtained from the Management
f all health facilities prior to the study.
esults
escription of study facilities
The distribution of the ten health facilities considered for this
tudy is presented in Table 1 along with their geographic coordi-
ates in Lagos and Ogun States. The annual average of antenatal
isits across these facilities ranges from a 120 patients to 4500
atients with an overall estimated average of 1219 patients per
ear. (This excludes the Akute Ajuwon centre with no information
vailable). The overall response rate for this study was 100%.
rief description of study participants
The distribution of study participants across the ten facilities
y socio-demographic characteristics is presented in Table 2. A
otal of 353 patients gave consent to participate in the study with
00% response rate. Highest rate of participation was found among
regnant women  in the middle age category (25–34 years) com-
rising of at least 60% of respondents across all the health facilities
Table 2). Highest rate of respondents in between the age of 15 and
4 years was observed in the Mowe  health centre (23%). On the
ther hand, the highest percent of respondents age 35 years and
bove was found in Kollington and Ipaja centres respectively. A
igniﬁcant number of the respondents (≥80%) were married with
t least primary or higher education. This trend was  consistently
bserved across the ten facilities.
IV prevalence in study population
Table 3 shows the distribution of HIV seropositivity status of
he survey respondents tested across the ten facilities. Findings
howed that of the 353 pregnant women tested for HIV antibod-
es, 18 tested positive giving an overall prevalence estimate of 5.1%
95% CI:3.0%–7.9%) in the study population. The highest prevalence
ate was observed in the Redemption camp while the lowest rate
f 0% was observed across six health facilities.
IV prevalence estimates distribution by socio-demographic
haracteristicsWe  further characterize prevalence rate distribution by socio-
emographics of study participants as presented in Table 3. Highest
revalence rate was observed in pregnant women age 35 years and36(73.5) 6(24) 22(48.9) 12(29) 12(31) 145(42)
3(6.1) 8(32) 10(22.2) 3(7) 4(10) 48(14)
10(20.4) 10(40) 12(26.7) 27(64) 23(59) 147(42)
above (6.9%) closely followed by those in the middle age group
(5.3%). However, no signiﬁcant association was found between age
group and the likelihood of HIV infection in the study population.
In addition, pregnant women from Ogun State are almost 3 times as
likely to test HIV positive compare to their counterparts from Lagos
State (Table 3) with a marginal evidence of signiﬁcant difference
observed between these two study sub-populations. On the other
hand, a dose-response relationship was found between the likeli-
hood of HIV infection and the number of previous children reported.
Highest rate of 10.6% was  observed in pregnant women who  have
had at least 2 children previously and this relationship was  statis-
tically signiﬁcant (Table 3). Consequently, the higher the number
of children reported, the higher the likelihood of HIV infection. In
contrast, while the highest rate of HIV infection was  observed in
pregnant women  with higher education (6.1%), this was not found
to be statistically different from prevalence rates observed in preg-
nant women  with primary (4.8%) or secondary education (4.2%).
Results of TB test and syndromic screening for tuberculosis
The overall estimate of tuberculosis rate in the study popu-
lation was 0% as none of the pregnant women  tested positive
to the immunoﬂuorescence assay test. This study also conducted
a syndromic assessment of tuberculosis in the study population
according to WHO  guidelines. The results are presented in Table 4.
The rates of cough more than 3 weeks and weight loss were esti-
mated at 4% and 2% respectively. On the other hand a statistically
signiﬁcantly higher rate of lymphadenopathy (20%) was observed
notably across six of the ten health facilities (Table 4). An estimated
24% of the study population reported having fever that lasted more
than 3 weeks. However this did not attain statistical signiﬁcance.
A comparative assessment of HIV knowledge and exposure
In order to further our understanding and characterization of
the observed patterns in this population of pregnant women, we
assessed the knowledge and exposure proﬁle of HIV positive and
negative pregnant women as presented in Table 4. We  found highly
statistically signiﬁcant evidence in the difference between the two
study sub-populations with respect to previous negative HIV test
(Table 4). Findings showed that 49.5% of HIV negative pregnant
women had had previous negative HIV test compared to 16.7%
of HIV positive pregnant women  (p = 0.007). On the other hand,
a relatively high proportion of both populations had knowledge of
HIV transmission routes and risk factors (>90%). A similar high per-
centage of both HIV positive and negative pregnant women were
informed about the test results (Table 5).
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Table  3
Statistical comparison of HIV seropositivity status with regard to socio-demographic variables.
Variable N HIV positive n (%) HIV negative n (%) p-value
Age 0.307; chi2(2) = 2.364
15–24 35 0(0) 35(100)
25–34 245 13(5.3) 232(94.7)
≥35 73 5(6.9) 68(93.2)
State of origin 0.084; Chi2(1) = 2.992
Lagos 126 3(2.4) 123(97.6)
Ogun 227 15(6.6) 212(93.4)
Parity 0.007; Chi(2) = 9.846; Fisher’s exact = 0.012
0  74 1(1.4) 73(98.7)
1  135 4(3.0) 131(97.0)
≥2  104 11(10.6) 93(89.4)
Education 0.853; Chi2(3) = 0.784
None 7 0(0) 7(100)
Primary 145 7(4.8) 138(95.2)
Secondary 48 2(4.2) 46(95.8)
Higher 147 9(6.1) 138(93.9)
Total 353 18(5.1) 335(94.9)
Table 4
Distribution of syndromic indicators of tuberculosis among study participants by study locations.
Indicator 1 N = 39
n(%)
2 N = 29
n(%)
3 N = 20
n(%)
4 N = 20
n(%)
5 N = 40
n(%)
6 N = 51
n(%)
7 N = 26
n(%)
8 N = 45
n(%)
9 N = 43
n(%)
10 N = 40
n(%)
Total N = 353
n(%)
Cough >3 weeks?
No 38(97) 29(100) 19(95) 17(85) 38(95) 49(96) 25(96) 43(96) 43(100) 38(95) 339(96)
Yes  1(3) 0(0) 1(5) 3(15) 2(5) 2(4) 1(4) 2(4) 0(0) 2(5) 14(4)
p-val:  0.361
Weight loss
No 39(100) 29(100) 20(100) 20(100) 39(98) 49(96) 26(100) 44(98) 43(100) 38(95) 347(98)
Yes  0(0) 0(0) 0(0) 0(0) 1(2) 2(4) 0(0) 1(2) 0(0) 2(5) 6(2)
p-val:  0.583
Lymphadenopathy
No 26(67) 29(100) 16(80) 20(100) 30(75) 37(73) 25(96) 35(78) 34(79) 32(80) 284(80)
Yes  13(33) 0(0) 4(20) 0(0) 10(25) 14(27) 1(4) 10(22) 9(21) 8(20) 69(20)
p-val:  0.005
Fever >3 weeks?
No 29(74) 28(97) 13(65) 13(65) 32(80) 37(73) 20(77) 35(78) 36(84) 27(68) 270(76)
Yes  10(26) 1(3) 7(35) 7(35) 8(20) 14(27) 6(23) 10(22) 7(16) 13(32) 83(24)
p-val:  0.148
Sweat >3 weeks?
No 37(95) 29(100) 20(100) 20(100) 40(100) 50(98) 25(96) 44(98) 43(100) 38(95) 346(98)
Yes  2(5) 0(0) 0(0) 0(0) 0(0) 1(2) 1(4) 1(2) 0(0) 2(5) 7(2)
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In addition, a statistically signiﬁcant association was found
etween blood transfusion in the past 3 months and HIV infection.
IV positive pregnant women were 6 times more likely to have
lood transfusion in the past 3 months than HIV negative pregnant
omen. We  also noted the marginal association between sexually
ransmitted infection (STI) in the past 3 months and HIV infection
s HIV positive pregnant women had 2 times higher rate of STI than
IV negative pregnant women (Table 5).
nferential analysis of HIV risk in the study population
As a further step, we examined any evidence for differences
etween HIV positive and negative sub-populations with regard
o HIV knowledge and exposure proﬁle as presented in Table 5.
esults showed a statistically signiﬁcant difference between preg-
ant women that tested HIV positive compared to those tested
egative with respect to previously tested negative result (p < 0.01).
imilarly, statistical evidence was found between blood transfu-
ion in the past three months and likelihood of HIV infection.
he results showed that 11.1% (n = 2/18) of HIV positive patients
ad blood transfusion in the previous three months compared to
.8% (n = 6/333). It is also worth mentioning that we  found no
vidence of association between HIV infection and having unpro-mp; 7—Ipaja; 8—Kollington; 9—Mowe; 10—Sabo Ikorodu.
tected sex with casual partner as all HIV positive participants
had no unprotected sex with a casual partner in the previous
3 months. A marginal evidence was found between sexually
transmitted infection in the past 3 months and the risk of HIV
infection. The result showed that HIV positive pregnant women
are two  times more like to be diagnosed of STI in the past three
months.
We ﬁtted a binary logistic regression model to estimate adjusted
effect of signiﬁcant factors that may  increase the likelihood of
HIV infection in this study population. The result is presented
in Table 6. Pregnant women  from Ogun State had 4.72 greater
odds of HIV infection compared to those from Lagos State. A
dose-response effect of parity on the risk of HIV infection was
also observed with pregnant women who  had had at least 2
children previously having 9.8 greater odds of HIV compared to
those who  did not have any child. On the other hand, pregnant
women with previously tested HIV negative status had signiﬁcantly
lower odds of HIV infection (OR:0.21, 95% CI:0.06–0.77). A three
times greater odds of HIV infection was also observed in preg-
nant women with history of blood transfusion in the previous three
months.
G. Atilola et al. / Journal of Infection and Public Health 11 (2018) 826–833 831
Table  5
Assessment of the differences between HIV positive and negative participants with respect to HIV knowledge and exposure proﬁle.
Variable N HIV positive n (%) HIV negative n (%) p-value
Previously tested HIV negative 0.007; chi2(1) = 7.400 exact; 0.007
No  183 15(83.3) 168(50.5)
Yes  168 3(16.7) 165(49.5)
Awareness of HIV transmission routes 0.194; chi2(1) = 1.688 exact; 0.271
No  6 1(5.6) 5(1.5)
Yes  347 17(94.4) 330(98.5)
Risk  factors awareness 0.195; chi2(1) = 1.679 exact; 0.272
No  6 1(5.6) 5(1.5)
Yes  346 17(94.4) 329(98.5)
Awareness of transmission methods 0.127; chi2(1) = 2.327 exact; 0.231
No  5 1(5.6) 4(1.2)
Yes  348 17(94.4) 331(98.8)
Informed about test result 0.127; chi2(1) = 2.327 exact; 0.231
No  5 1(5.6) 4(1.2)
Yes  348 17(94.4) 331(98.8)
Blood  transfusion in the past 3 months 0.010; chi2(1) = 6.645 exact; 0.058
No  343 16(88.9) 327(97.6)
Yes  8 2(11.1) 6(1.8)
Non-response 2 0(0) 2(0.6)
Unprotected sex with casual partner in the past 3 months 0.640; chi2(1) = 0.219 exact; 1.000
No  347 18(100.0) 329(98.2)
Yes  4 0(0.0) 4(1.2)
Unprotected sex with regular partner <=3 months 0.480; chi2(1) = 0.499 exact; 1.000
No  9 0(0.0) 9(2.7)
Yes  342 18(100.0) 324(96.7)
Non-response 2 0(0) 2(0.6)
STI  in the past 3 months 0.050; chi2(1) = 3.856 exact; 0.094
No  292 12(66.7) 280(83.6)
Yes  58 6(33.3) 52(15.5)
Non-response 3 0(0) 3(0.9)
More  than one sex partner in the past 3 months 0.640; chi2(1) = 0.219 exact; 1.000
No  347 18(100.0) 329(98.2)
Yes  4 0(0.0) 4(1.2)
Non-response 2 0(0) 2(0.6)
HIV  risk score 0.003
Mean ± SD 351 2.50 ± 0.71 2.15 ± 0.47
Age at ﬁrst sex 0.785
Mean ± SD 21.4 ± 3.8 21.7 ± 4.6
Table 6
Binary Logistic Regression Model of HIV infection in the study population of pregnant women.
Variable Odds ratio (95% CI) S.E P-value(<0.05)
Age at ﬁrst sex 0.96 (0.84–1.09) 0.07 0.502
State  of origin
Lagos Ref
Ogun 4.72 (0.99–22.59) 3.8 0.052
Parity
0  Ref
1  2.43 (0.25–23.42) 2.81 0.442
≥2  9.77 (1.17–81.80) 10.59 0.036
Previously tested HIV negative
No Ref
Yes 0.21 (0.06–0.77) 0.14 0.019
Blood transfusion in the past 3 months
No Ref
Yes 3.27 (0.44–24.36) 3.35 0.248
Complaints of genital sore/swollen of inguinal lymph
No Ref
2 (0.2
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ssessment of impact measures of risk factors for HIV infection on
he pregnant women population
In order to evaluate the public health impact associated with
isk reduction within exposure risks groups, we implemented two
easures of impact of exposure group on HIV infection. These arehe attributable proportion (often described as attributed fraction)
hich measures proportion of cases attributable to the exposure
isk, as well the population attributable fraction, a similar measure4–26.26) 3.01 0.440
andard error.
that extends the attributable proportion in the entire study popu-
lation. The important caveat here is that we considered the odds of
infection, rather than risk as commonly applied in cohort studies
in recognition of the cross-sectional study design of the study. The
results of this assessment are presented in Table 7.
Three exposure risk factors were found to have a statisti-
cally signiﬁcant impact on the attributable fraction and population
attributable fraction respectively. They are parity (at least two pre-
vious children), blood transfusion in the previous three months
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Table  7
Attributable proportion and population attributable fraction of key HIV socio- demographic and exposure variables.
Exposure OR (95%CI) AFexp/APexp(95%CI) PFexp (95%CI) PAF/PFpop p-value(exact)
Education
Primary 0.91(0.34–2.40) – 0.09(−1.40 to 0.66) 0.038 1.000
Secondary 0.79(0.18–3.52) – 0.22(−2.52 to 0.82) 0.029 1.000
Higher 1.43(0.55–3.68) 0.30(−0.80 to 0.73) – 0.150 0.472
Parity
0  0.21(0.03–1.35) – 0.79(−0.35 to 0.97) 0.172 0.137
1  0.44(0.15–1.35) – 0.56(−0.35 to 0.85) 0.217 0.213
2  4.09(1.64–10.20) 0.76(0.39–0.90) – 0.462 0.006
Age  group
25–34 1.15(0.40–3.32) 0.13(−1.50 to 0.70) – 0.097 1.000
>=  35 1.51(0.52–4.36) 0.34(−0.91 to 0.77) – 0.094 0.548
State of Origin
Lagos 0.34(0.10–1.15) – 0.66(−0.15 to 0.90) 0.241 0.128
Ogun 2.90(0.87–9.71) 0.66(−0.15 to 0.90) – 0.546 0.128
Previously tested HIV negative 0.20(0.06-0.64) – 0.80(0.36–0.94) 0.395 0.007
Blood transfusion in the past 3 months 6.81(1.58–29.36) 0.853(0.37–0.97) – 0.095 0.058
STI  in the past 3 months 2.69(1.00–7.24) 0.629(0.00–0.86) – 0.210 0.094
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told values are the probability that the population attributable fraction (PAF) or pre
t  5% alpha level.
nd having previously tested negative. The attributable proportion
f all cases of HIV infection in pregnant women with at least 2
revious children was 76%, and this was found to be statistically
igniﬁcant after adjusting for socio-demographic factors. Similarly,
5% of all cases exposed to blood transfusion in the previous three
onths are due to the effect of blood transfusion in the study pop-
lation. While we obtained 80% preventive fraction in pregnant
omen who tested negative compared to those who tested positive
n previous test.
iscussion
In the present study, we conducted an epidemiological assess-
ent of the HIV and tuberculosis co-burden in pregnant women
opulation in two south-western states in Nigeria. The overall
revalence estimate of HIV was 5.1% while tuberculosis was 0% in
his high risk population (H¨IV prevalence in study population)¨.
A comparison of these ﬁndings to the most recent National HIV
revalence estimate of 2.9% in 2016 shows relatively higher rate
bserved among pregnant women in Lagos and Ogun states [20].
IV prevalence estimate in our study was slightly higher than the
010 National ANC average HIV prevalence rate of 4.1% in pregnant
omen [21]. A comparison of this result to other similar studies
how evidence of a relatively lower rate than the 8.2% and 8.3%
eported by Sagay et al. [22] and Charles et al. [23] in Jos; 7.7%
nd 11.5% reported by Adeyemo et al. [24] and Agboghoroma and
Iliyasu [25] reported in Ogun state and Abuja respectively. On the
ther hand, prevalence estimate from this study was  slightly higher
han similar studies conducted in Port Harcourt [26], the Nigeria
elta region of the country [27,28] and south-eastern Nigeria
Umeononihu et al. [29] with estimates ranging from 3%–4.9%. We
lso reported a high prevalence rate among pregnant women from
gun state 6.6% compared with pregnant women from Lagos State
2.2%). The observed higher rate in Ogun state may be due to the
igher demands, availability, and affordability of antenatal health
are services both at the government level and private centers.
The relatively higher education and exposure to preventive
easures, and easy access to treatment regimen in teaching hos-
itals in the metropolitan city of Lagos may  account for the
ffectiveness of interventions and subsequent reduction in HIV
ransmission particularly in between regular partners. In addition,
he observation of highest rate of HIV infection in pregnant womene fraction in the population (PFpop) for the exposure attained statistical signiﬁcance
in the middle (26–34 years) age group was expected and consistent
with reports from various studies [7,30]. Women of reproductive
age tend to peak in their sexual activity in the middle age years
(25–34 years) and hence with higher transmission probability of
HIV particularly with non-use or inconsistent use of protective
measures.
Another notable ﬁnding from this study is the observed dose-
response relationship between parity and the likelihood of HIV
infection in the pregnant women population. This likelihood is sig-
niﬁcantly ampliﬁed with increasing number of parity (I¨nferential
analysis of HIV risk in the study population)¨. This may  be due to
the fact that women with multiple parity are particularly prone to
pregnancy-related immune-suppression which makes them more
predispose with each new episode of pregnancy [9]. On the other
hand, longer history of parity invariably translates to higher fre-
quency of antenatal care visit to health centers which is another key
source of HIV exposure through unsterilized medical instruments,
blood and blood products as found in our study.
Furthermore, we found a 6 times higher rate of blood trans-
fusion in the previous 3 months in HIV positive pregnant women
(I¨nferential analysis of HIV risk in the study population)¨. This
provides evidence for the possibility of the transmission (epidemi-
ological) link between recent blood transfusion and HIV positivity
in this population. This is not uncommonly reported as it has been
shown that despite the low probability of HIV infection through
contaminated blood products, this route of transmission can be
greatly enhance and a likely persisting cause for concern across
developing countries particularly in sub-Saharan Africa with an
ongoing and highly heterosexual generalized HIV epidemic in
multi-organism transmission complex environment [30–32]. The
85% of all cases attributed to blood transfusion within the study
population demonstrate the protective impact of ensuring ade-
quate screening of blood and blood products in healthcare settings
particularly prior to antenatal care.
There is therefore little evidence of a declining HIV burden in
pregnant women  population.
This may  be due to a number of factors that we assessed in
the current study which more often than not predispose preg-
nant women to HIV exposure such as unprotected sex with regular
partners who may  or may  not be faithful. The second is related to
hospital-acquired HIV infection through infected blood and blood
n and
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lence of transfusion transmissible infections (TTI), in ﬁrst time blood donors in
Abeokuta, Nigeria. Afr Health Sci 2015;15(1):19–24.G. Atilola et al. / Journal of Infectio
roducts, a frequent occurrence in developing countries with poor
ealthcare infrastructure.
We further assessed the tuberculosis situation in the same pop-
lation as the most ranked opportunistic infection and risk factor
or HIV due to the immune-suppressed state of pregnant women.
owever, we found no case of active tuberculosis (0%) in this pop-
lation despite the high prevalence of HIV. This may  be due to the
ositive impact of DOTS intervention over the years as part of the
outine antenatal care services across Nigeria.
imitations of the study
This study was designed to be a cross-sectional study of the
regnant women population in south west Nigeria. As a result,
oth exposure and outcome measures were collected at the same
oint in time which makes risk estimates difﬁcult with regard to
he temporal nature of exposure and outcome. This is a well-known
imitation to all cross-sectional studies and thus result of such stud-
es must be interpreted with caution. The second limitation of the
tudy relates to the representativeness of the total sample size
btained for the study. Due to funding limitation, we  only screened
53 pregnant women across ten health facilities. Consequently, this
ay  affect the external validity of this study and thus renders the
stimates of HIV prevalence burden obtained less generalizable to
ther parts of the country; hence, we consider this an improved
stimate.
unding
No funding Sources.
ompeting interests
None declared.
thical approval
Not required.
eferences
[1] World Health Organization (WHO). Global Tuberculosis report, http://www.
who.int/tb/publications/global report/en/; 2017 [Accessed 19 March 2018].
[2]  UNAIDS. Global AIDS update 2016, http://www.unaids.org/sites/default/ﬁles/
media asset/global-AIDS-update-2016 en; 2016 [Accessed 19 March 2018].
[3]  Onakewhor JU, Olagbuji BN, Ande AB, Ezeanochie MC,  Olokor OE, Okonofua
FE.  HIV-AIDS related maternal mortality in Benin City, Nigeria. Ghana Med J
2011;45(2):54–9.
[4] Mayer K, Gupta A. Tuberculosis in pregnant and postpartum women: epidemi-
ology, management, and research gaps. Clin Infect Dis 2012;55(11):1532–49.
[5] Ezechi O, Petterson K, Byamugisha J. HIV/AIDS, Tuberculosis, and malaria in
pregnancy. J Pregnancy 2012;2012:3. Article ID 140826.
[6] Awofala AA, Ogundele OE. HIV epidemiology in Nigeria. Saudi J Biol Sci
2016;25(4):697–703.
[7] Olakunde BO, Adeyinka DA, Oladele T, Ozigbu CE. HIV testing among male
partners of pregnant women in Nigeria: a missing link in the elimination of
mother-to-child-transmission of HIV. Int J STD AIDS 2017.
[8] Odaibo GN, Olaleye DO, Heyndrickx L, Vereecken K, Houwer K, Jassens
W.  Mother-to-child transmission of different HIV-1 subtypes among ARV
Naïve infected pregnant women in Nigeria. Rev Inst Med  trop Sao Paulo
2006;48(2):77–80.
[9] Lathrop E, Jamieson D, Danel I. HIV and maternal mortality. Int J Gynaecol Obstet
2014;127(2):213–5.
[ Public Health 11 (2018) 826–833 833
10] ] Zaba B, Calvert C, Marston M,  Isingo R, Nakiyingi-Miiro J, Lutalo T, Crampin
A,  Robertson L, Hervst K, Newell M,  Todd J, Byass P, Boerma T, Ronsmans C.
Effect of HIV infection on pregnancy-related mortality in sub-Saharan Africa:
secondary analyses of pooled community-based data from the network for
analysing longitudinal population-based HIV/AIDS data on Africa (ALPHA).
Lancet 2013;381(9879):1763–71.
11] Dierberg K, Chaisson R. HIV-Associated Tuberculosis: update on prevention and
treatment. Clinical Chest Med  2014;34(2):217–28.
12] Alan KK, Weaver MR,  Ogungbemi MK,  Ashefor G, Anenih J, Adeyemi A, et al.
Prevalence of tuberculosis and HIV/AIDS co-infection among HIV clients at
global fund supported comprehensive facilities in Nigeria. Int Res Med Sci
2016;4(6):91–5.
13] Nwabuko CO, Ejele OA, Chuku A, Nnoli MA,  Chukwuonye II. Prevalence
of Tuberculosis-HIV coinfection and relationship between Tuberculosis and
CD4/ESR in HIV patients in Niger Delta Region of Nigeria. ISOR J Dent Med
Sci 2012;2(4):1–4.
14] Matthew AO, Gbenga AO, Olamide SO, Aderonke A, Gani IM,  Nnamdi O.
Tuberculosis and HIV coinfection among patients attenting directly observed
treatment short course (DOTS) in Lagos. Nigeria 2015;7(7):69–74.
15] Odaibo G, Okonkwo P, Lawal O, Olaleye D. HIV infection among newly diag-
nosed TB patients in Southwest Nigeria: a multi-DOTS center study. World J
AIDS 2013;3(2):154–9.
16] ] Kolade R, Atilola G, Babalola V, Komolafe O. HIV-TB co-infection and associ-
ated risk factors among HIV positive patients at Olabisi Onabanjo University
Teaching hospital, Ogun state. South west Nigeria 2016;15(2):69–72.
17] Sidibe M,  Loures L, Samb B. The UNAIDS 90-90-90 target: a clear choice
for ending AIDS and for sustainable health and development. J Int AIDS Soc
2016;19(1):21133.
18] Levi J, Raymond A, Pozniak A, Vernazza P, Kohler P, Hill A. Can the UNAIDS
90-90-90 target be achieved? A systematic analysis of national HIV treatment
cascades. BMJ  Global Health 2016;1:e000010.
19] Adebimpe WO,  Asekun-Olarinmoye EO, Hassan AO, Abodunrin OL,  Olarewaju
S,  Akindele AA. Treatment outcomes among human immunodeﬁciency virus
and tuberculosis co-infected pregnant women in resource poor settings of
Southwestern Nigeria. Sierra Leone J Biomed Res 2011;3:151–6.
20] CIA World Factbook. HIV/AIDS — adult prevalence rate compares the percent-
age of adults (aged 15–49) living with HIV/AIDS, 2016. https://www.cia.gov/
library/publications/the-world-factbook/rankorder/2155rank.html; [Accessed
21  March 2018].
21] Bashorun A, Nguku P, Kawu I, Ngige E, Ogundiran A, Sabitu K, Nasidi A, Nsubuga
P.  A description of HIV prevalence trends in Nigeriafrom 2001 to 2010: what is
the progress, where is the problem? Pan Afr Med  J 2014;18(Suppl. 1):3.
22] Sagay AS, Kapiga SH, Imade GE, Sankale JL, Idoko J, Kanki P. HIV infection among
pregnant women in Nigeria. Int J Gynaecol Obstet 2005;90(1):61–7.
23] Charles A, Tinuade O, Jonah M,  Mercy I, Ifechi A, Christian I. HIV prevalence
amongst pregnant women clients attending antenatal clinic at the Faith Alive
Foundation and PMTCT Centre, Jos Plateau State. World J AIDS 2016;6:59–64.
24] Adeyemo BO, Gayawan E, Olusile AO, Komolafe IOO. Prevalence of HIV infection
among pregnant women presenting to two hospitals in Ogun state, Nigeria. HIV
AIDS Rev 2014;13(3):90–4.
25] Agboghoroma CO, Illiyasu Z. HIV prevalence and trends among preg-
nant women  in Abuja, Nigeria: a 5-year analysis. Trop J Obstet Gynaecol
2015;32(1):82–9.
26] Okerentugba PO, Uchendu SC, Okonko IO. Prevalence of HIV among preg-
nant women  in Rumubiakani, Port Harcourt Nigeria. Public Health Res
2015;5(2):58–65.
27] Egesie U, Mbooh RT. Seroprevalence of Human Immunodeﬁciency Virus (HIV)
infection in pregnant women in Amassoma Nigeria. African J Biomed Res
2007;11:111–3.
28] Ibrahim IA, Owoeye GIO, Obilahi A. The burden of HIV  infection among women
attending antenatal clinic in a semi-urban Nigeria town. West Indian Med  J
2013;62(4):323–8.
29] Umeononihu O, Ikechebelu J, Okonkwo J, Udigwe G, Mbachu I. The prevalence
of  HIV sero-positivity in late pregnancy among antenatal attendees with sero-
negative status in ﬁrst half of pregnancy in Nnewi, South East Nigeria. J HIV
Hum Reprod 2013;1(1):25–9.
30] Etukumana EA, Thacher TD, Sagay AS. HIV risk factors among pregnant women
in a rural Nigerian hospital. West Indian Med  J 2010;59(4):424–8.
31] Motayo BO, Faneye AO, Udo UA, Olusola BA, Ezeani I, Ogiogwa JI. Seropreva-32] Olajubu FA, Osinupebi OA, Deji-Agboola M,  Jagun EO. Seroprevalence of HIV
among blood donors, antenatal women and other patients in a tertiary hospital
in  Nigeria. Braz J Infect Dis 2009;13(4):280–3.
